Chapter 17 Cardiac Stimulants and Depressants The Heart

  • Slides: 19
Download presentation
Chapter 17 Cardiac Stimulants and Depressants

Chapter 17 Cardiac Stimulants and Depressants

The Heart The heart is a four-chamber organ located in the upper left thoracic

The Heart The heart is a four-chamber organ located in the upper left thoracic cavity. Purpose l l £ £ Pumps the blood around the body so that oxygen and nutrients can be distributed to all areas of the body Maintains the blood pressure at an acceptable level 2 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antiarrhythmics and Antianginals Cardiac illnesses l £ £ Cardiac stimulants Cardiac depressants 3 Copyright

Antiarrhythmics and Antianginals Cardiac illnesses l £ £ Cardiac stimulants Cardiac depressants 3 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Treatment of Heart Failure Cardiac glycosides l £ £ Digoxin Treat arrhythmias 4 Copyright

Treatment of Heart Failure Cardiac glycosides l £ £ Digoxin Treat arrhythmias 4 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Digoxin Decreases electrical conduction Prolongs refractory period Increases the force of the myocardial contraction

Digoxin Decreases electrical conduction Prolongs refractory period Increases the force of the myocardial contraction l l l £ Positive inotropic action 5 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Digoxin: Dose Considerations Duration of action Method of administration Other l l l £

Digoxin: Dose Considerations Duration of action Method of administration Other l l l £ £ £ Physical size of the client Other medications Renal or hepatic function Advanced age Presence of other illnesses 6 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antiarrhythmics and Antianginals Require a digitalizing dose l £ £ To bring serum levels

Antiarrhythmics and Antianginals Require a digitalizing dose l £ £ To bring serum levels to a therapeutic level All glycosides have a low therapeutic level 7 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antiarrhythmics and Antianginals: Side Effects Gastrointestinal effects l £ £ £ Nausea and vomiting

Antiarrhythmics and Antianginals: Side Effects Gastrointestinal effects l £ £ £ Nausea and vomiting Anorexia Diarrhea Cardiac effects l £ 8 Cardiac arrhythmias (continues) Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

(continued) Antiarrhythmics and Antianginals: Side Effects Neurological effects l £ £ £ Restlessness Irritability

(continued) Antiarrhythmics and Antianginals: Side Effects Neurological effects l £ £ £ Restlessness Irritability Drowsiness Vision changes Headache 9 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Cardiac Glycoside Toxicity l Predispose to cardiac glycoside toxicity £ £ £ 10 Hypokalemia

Cardiac Glycoside Toxicity l Predispose to cardiac glycoside toxicity £ £ £ 10 Hypokalemia Renal impairment Rapid IV administration (continues) Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

(continued) Cardiac Glycoside Toxicity l Treatment £ £ £ Stop the drug Physical assessment

(continued) Cardiac Glycoside Toxicity l Treatment £ £ £ Stop the drug Physical assessment Check potassium level u £ Administer if needed Monitor heart rate u Administer antiarrhythmics 11 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antiarrhythmic and Antidysrhythmic Drugs l Grouped together according to their similar actions 12 Copyright

Antiarrhythmic and Antidysrhythmic Drugs l Grouped together according to their similar actions 12 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antiarrhythmics and Antianginals: Drug Action l Work three ways: £ £ £ Decrease the

Antiarrhythmics and Antianginals: Drug Action l Work three ways: £ £ £ Decrease the automaticity of cardiac tissues in the ectopic sites Alter the rate of conduction of electrical impulses through the heart. Alter the refractory period of cardiac muscle between consecutive contractions 13 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antidysrhythmic Agents l l Group 1, 1 A, 1 B, 1 C: decrease the

Antidysrhythmic Agents l l Group 1, 1 A, 1 B, 1 C: decrease the influx of sodium ions, stabilizing membranes Group 2: depress phase 4 in depolarization Group 3: prolong repolarization in phase 3 Group 4: depress phase 4 depolarization and prolong repolarization of phases 1 and 2 14 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Beta-adrenergic Blocking Agents l l l Inhibit beta 1 and beta 2 sympathetic receptors

Beta-adrenergic Blocking Agents l l l Inhibit beta 1 and beta 2 sympathetic receptors Reduce heart rate Reduce contractility Decrease supraventricular and ventricular rhythms Decrease blood pressure 15 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Antidysrhythmic Agents l Adverse effects £ £ l Cause bronchoconstriction Cause heart failure Examples:

Antidysrhythmic Agents l Adverse effects £ £ l Cause bronchoconstriction Cause heart failure Examples: propanolol (Inderal), esmolol, bretylium tosylate (Bretylol) 16 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Calcium Channel Antagonists l Reduce the influx of calcium into the cell: £ Prevention

Calcium Channel Antagonists l Reduce the influx of calcium into the cell: £ Prevention or reversal of spasms of the coronary blood vessels u u l Coronary artery dilation Reduction of myocardial oxygen consumption Example: verapamil 17 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Adenosine l l l Slow conduction through the AV node Cardioverts paroxysmal supraventricular tachycardia

Adenosine l l l Slow conduction through the AV node Cardioverts paroxysmal supraventricular tachycardia (PSVT) Side effects £ £ Facial flushing Shortness of breath Headache Nausea and vomiting 18 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

Adrenergic or Sympathomimetic Drugs l l Affect alpha- or beta-adrenergic receptors Treat shock £

Adrenergic or Sympathomimetic Drugs l l Affect alpha- or beta-adrenergic receptors Treat shock £ £ Mimic epinephrine and/or norepinephrine Cause increase in heart rate Cause vasoconstriction Reverse hypotension from shock u Cardiac or trauma 19 Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.